Area of research
Immunology · Infectious Diseases · mRNA vaccine adjuvant
Research interest
Research interests include Immunotherapy and Immune Responses, Immune Response and Inflammation, SARS-CoV-2 and COVID-19 Research, and COVID-19 Clinical Research Studies.
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial